Implant Roughness and Volume Increase Lymphoma Risk in Case-Control Study

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) remains a critical concern for clinicians managing both aesthetic and reconstructive patients [1, 2]. While the association between textured surfaces and this T-cell malignancy is well established, the specific roles of surface topography and device volume in pathogenesis have remained less clear [3, 4]. Surgeons often face a clinical dilemma when counseling asymptomatic patients, as historical data has been insufficient to confirm whether electively replacing textured devices with smooth alternatives effectively mitigates future oncologic risk [5, 6]. Furthermore, the trade-off between reducing lymphoma risk and potentially increasing rates of capsular contracture continues to complicate surgical decision-making [7, 8]. A new multicenter study now provides specific data on how implant characteristics and replacement histories influence the likelihood of disease onset, offering physicians a clearer framework for risk stratification.